Price is holding up well, despite hold-ups in the approval process. Maybe they are holding discussions with potential partners for the Phase III trial that lies ahead.
I don't expect to hear anything until next month at the earliest.
SLA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held